ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
14
views
0
references
Top references
cited by
93
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,756
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Myelofibrosis with myeloid metaplasia.
Author(s):
A Tefferi
Publication date:
2000-04-27
Journal:
The New England journal of medicine
Keywords:
Antineoplastic Agents
,
therapeutic use
,
Bone Marrow
,
pathology
,
Diagnosis, Differential
,
Hematopoietic Stem Cell Transplantation
,
Humans
,
Hydroxyurea
,
Primary Myelofibrosis
,
complications
,
diagnosis
,
therapy
,
Prognosis
,
Splenectomy
,
Suramin
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Neuropharmacology and Therapy
Author and article information
Journal
PubMed ID::
10781623
DOI::
10.1056/NEJM200004273421706
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Agents
,
therapeutic use
,
Bone Marrow
,
pathology
,
Diagnosis, Differential
,
Hematopoietic Stem Cell Transplantation
,
Humans
,
Hydroxyurea
,
Primary Myelofibrosis
,
complications
,
diagnosis
,
therapy
,
Prognosis
,
Splenectomy
,
Suramin
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Agents
,
therapeutic use
,
Bone Marrow
,
pathology
,
Diagnosis, Differential
,
Hematopoietic Stem Cell Transplantation
,
Humans
,
Hydroxyurea
,
Primary Myelofibrosis
,
complications
,
diagnosis
,
therapy
,
Prognosis
,
Splenectomy
,
Suramin
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,756
Benign osseous metaplasia of the breast: Case report
Authors:
Hassan Alyami
,
Emad Al-Osail
,
Shawgi Harbi
…
Factors to improve the interobserver agreement for gastric atrophy and intestinal metaplasia: consensus of definition and criteria.
Authors:
Sung Kim
,
Myeong-Cherl Kook
,
Ok-Ran Shin
…
Adherence to the Sydney System guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400738 sets of gastric biopsies.
Authors:
J Lash
,
R M Genta
See all similar
Cited by
92
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Authors:
Yana Pikman
,
Benjamin Lee
,
Thomas Mercher
…
A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis
Authors:
A Pardanani
,
A Tefferi
,
C Jamieson
…
Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes
Authors:
Tariq Mughal
,
Kris Vaddi
,
Nicholas Sarlis
…
See all cited by